
Alpine Immune Sciences ALPN
Quarterly report 2024-Q1
added 05-09-2024
Alpine Immune Sciences P/S Ratio 2011-2026 | ALPN
Annual P/S Ratio Alpine Immune Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.94 | 8.95 | 26.1 | 31.5 | 131 | 41.5 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 131 | 8.94 | 41.3 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.429 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 16.81 | -2.83 % | $ 786 M | ||
|
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
2.13 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 7.58 | -3.19 % | $ 208 M | ||
|
Midatech Pharma plc
MTP
|
240 | - | -18.52 % | $ 27.3 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 4.08 | -7.39 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.61 | 1.26 % | $ 428 M | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.77 | -8.75 % | $ 259 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
BioNTech SE
BNTX
|
35.7 | $ 89.59 | -2.61 % | $ 21.7 B | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.6 | -2.15 % | $ 187 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
11.9 | $ 3.43 | -3.65 % | $ 5.65 M | ||
|
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 3.13 | 0.16 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
6.99 | $ 30.12 | -1.94 % | $ 810 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Exelixis
EXEL
|
5.05 | $ 50.55 | -1.08 % | $ 13.7 B | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 21.54 | -0.16 % | $ 2.74 B | ||
|
Fortress Biotech
FBIO
|
1.23 | $ 2.39 | 3.91 % | $ 66.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Forte Biosciences
FBRX
|
181 | $ 23.52 | -1.86 % | $ 305 M | ||
|
Fennec Pharmaceuticals
FENC
|
3.78 | $ 10.11 | 9.36 % | $ 289 M |